Get the app!
Back to Companies

Inhibrx Biosciences, Inc.

INBXNasdaqCIK: 0002007919

Inhibrx Biosciences, Inc. (INBX) shows 12 recent insider filings from 7 insiders, with 3 buying and 2 selling. With $4.0M in purchases and $11.6M in sales, the recent tape is net selling (net sales of $7.6M). VIKING GLOBAL INVESTORS LP is the most active by dollar volume, and the single largest transaction was $11.3M by VIKING GLOBAL INVESTORS LP. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.

Total Volume
$27.7M
Purchases
$4.0M
Sales
$11.6M
Unique Insiders
7

Recent Insider Trades

12 loaded
Sep 17INBX
Inhibrx Biosciences, Inc.
Kayyem Jon FaizDirectorBuy$500.0K
Sep 15INBX
Inhibrx Biosciences, Inc.
MANHARD KIMBERLYDirectorSell$163.5K
Sep 10INBX
Inhibrx Biosciences, Inc.
MANHARD KIMBERLYDirectorSell$115.5K
Sep 8INBX
Inhibrx Biosciences, Inc.
Kayyem Jon FaizDirectorBuy$567.6K
Sep 8INBX
Inhibrx Biosciences, Inc.
FORSYTH DOUGLASDirectorBuy$286.6K
Sep 8INBX
Inhibrx Biosciences, Inc.
Lappe MarkChief Executive Officer, DirectorBuy$2.6M
Jun 4INBX
Inhibrx Biosciences, Inc.
MANHARD KIMBERLYDirectorAward$1.4M
Jun 4INBX
Inhibrx Biosciences, Inc.
Kayyem Jon FaizDirectorAward$1.4M
Jun 4INBX
Inhibrx Biosciences, Inc.
FORSYTH DOUGLASDirectorAward$1.4M
Jun 4INBX
Inhibrx Biosciences, Inc.
Vuori Kristiina MDDirectorAward$1.4M
Apr 27INBX
Inhibrx Biosciences, Inc.
Matly DavidPresidentAward$6.5M
Oct 9INBX
Inhibrx Biosciences, Inc.
VIKING GLOBAL INVESTORS LPInsiderSell$11.3M

12 filings